Not finding it? Sign in to also search OpenAlex live.
-
Diagnostic Delay and the Clinical Prodrome in US Adults with Systemic Light Chain (AL) Amyloidosis with Renal Involvement2020 Journal of the American Society of Nephrology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Laura Hester, Dina Gifkins, Kevin M. Bellew, JESSICA T. VERMEULEN, Jordan Mark Schecter, Victor Dishy, +1 more
0citations -
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA2023 Annals of Hematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +16 more
13citations -
Subcutaneous Daratumumab (DARA) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival and Final Major Organ Deterioration Progression-Free Survival Results from the Phase 3 Andromeda Study2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Hans Chulhee Lee, +24 more
15citations -
Rapid and Deep Hematologic Responses Are Associated with Improved Major Organ Deterioration Progression-Free Survival in Newly Diagnosed AL Amyloidosis: Results from Andromeda2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Ashutosh D. Wechalekar, Giovanni O. Palladini, Giampaolo Merlini, Raymond L. Comenzo, Arnaud Jaccard, NamPhuong Tran, +6 more
6citations -
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Giovanni O. Palladini, Efstathios Kastritis, Mathew S. Maurer, Jeffrey A. Zonder, Monique C. Minnema, Ashutosh D. Wechalekar, +14 more
212citations -
Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 20192021 European Journal Of Haematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes cited by 2 patents
Laura Hester, Dina Gifkins, Kevin M. Bellew, JESSICA T. VERMEULEN, Jordan Mark Schecter, John T. Strony, +2 more
53citations -
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis2021 New England Journal of Medicine article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access cited by 1 patent
Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Hans Chulhee Lee, +43 more
701citations -
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis2022 JACC CardioOncology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Monique C. Minnema, Angela A. Dispenzieri, Giampaolo Merlini, Raymond L. Comenzo, Efstathios Kastritis, Ashutosh D. Wechalekar, +10 more
24citations -
Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study2022 American Journal of Hematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Vaishali Sanchorawala, Giovanni O. Palladini, Monique C. Minnema, Arnaud Jaccard, Hans Chulhee Lee, Simon DJ Gibbs, +28 more
10citations -
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation2024 Haematologica article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Laurent Garderet, Luuk A. Gras, Linda Köster, Liesbeth C. de Wreede, Rovira Montserrat, Laure Vincent, +20 more
5citations -
OAB-034: Evaluating the impact of cytogenetic abnormalities on treatment outcomes in patients with AL amyloidosis: subanalyses from the ANDROMEDA study2021 Clinical Lymphoma Myeloma & Leukemia conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Shaji Kunnathu Kumar, Angela A. Dispenzieri, Divaya Bhutani, Morie Abraham Gertz, Ashutosh D. Wechalekar, Giovanni O. Palladini, +10 more
2citations -
Long Term Outcomes and Renal Response Following Autologous Stem Cell Transplantation for Light Chain Deposition Disease:a Retrospective Study on Behalf of the Cmwp of the EBMT2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Laurent Garderet, Luuk A. Gras, Linda Köster, Montserrat Rovira, Laure Vincent, Guido Kobbe, +18 more
0citations -
Outcomes By Cardiac Stage in Newly Diagnosed AL Amyloidosis: Results from Andromeda2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Monique C. Minnema, Angela A. Dispenzieri, Giampaolo Merlini, Raymond L. Comenzo, Efstathios Kastritis, Ashutosh D. Wechalekar, +10 more
5citations -
Subcutaneous Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: 18-Month Analysis of the Phase 3 ANDROMEDA Study2021 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Raymond L. Comenzo, Giovanni O. Palladini, Efstathios Kastritis, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, +24 more
12citations -
Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study2020 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +15 more
2citations -
Valvular heart disease in transthyretin cardiac amyloidosis2025 European Heart Journal - Cardiovascular Imaging article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Camille Sarrazyn, Philippe Debonnaire, Francesca Graziani, Erwan Donal, Fausto José Pinto, S Droogmans, +9 more
0citations
22 results